SOCS3 is pathologically upregulated after neural injury/diseases to negatively regulate a broad range of cytokines/chemokines that mediate inflammation [13,25,26]; however, the spatiotemporal expression of SOCS3 in ALS has not been investigated previously. This evidence concerns the gene SOCS3 and amyotrophic lateral sclerosis.